fr 139317 has been researched along with copper phthalocyanine in 1 studies
| Studies (fr 139317) | Trials (fr 139317) | Recent Studies (post-2010) (fr 139317) | Studies (copper phthalocyanine) | Trials (copper phthalocyanine) | Recent Studies (post-2010) (copper phthalocyanine) |
|---|---|---|---|---|---|
| 219 | 0 | 8 | 320 | 0 | 54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, AL; Lee, JY; Opgenorth, TJ; Warner, RB | 1 |
1 other study(ies) available for fr 139317 and copper phthalocyanine
| Article | Year |
|---|---|
Endothelin ETA receptor antagonist reduces myocardial infarction induced by coronary artery occlusion and reperfusion in the rat.
Topics: Animals; Azepines; Endothelin Receptor Antagonists; Endothelins; Indoles; Male; Myocardial Infarction; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 1994 |